B-cell
B cells are lymphocytes derived from hematopoietic stem cells in bone marrow that play central roles in adaptive immunity through both antibody production and antigen presentation.
B cells are lymphocytes derived from hematopoietic stem cells in bone marrow that play central roles in adaptive immunity through both antibody production and antigen presentation. These cells are characterized by the expression of B cell receptors (BCRs) and major histocompatibility complex (MHC) class II molecules, enabling them to recognize antigens and present processed peptide fragments to T cells. During immune responses, B cells undergo clonal expansion and differentiation into plasma cells that synthesize antibodies, or into memory cells that provide long-lived protective immunity. Their developmental progression includes transition through germinal centers within lymphoid tissues, where B cells interact with follicular helper T cells and undergo somatic hypermutation and class switching to generate functionally diverse antibody isotypes.
Beyond antibody production, B cells function as professional antigen-presenting cells (APCs) that regulate immune responses through direct interactions with T cells via co-stimulatory molecules such as CD86 and ICOSL, and through modulation of inflammatory microenvironments in lymph nodes and tertiary lymphoid structures. Distinct B cell subsets—including classical and atypical B cells—exhibit specialized roles in tissue-resident immunity and systemic immune control, with genetic variants affecting B cell-specific gene expression contributing to susceptibility for autoimmune, infectious, and neurodegenerative diseases. The therapeutic targeting of B cells has proven effective in multiple disease contexts including autoimmune conditions and cancer, underscoring their importance as both central effectors of protective immunity and drivers of pathological inflammation when dysregulated.
Where the papers sit
14 papers from the last 6 months study b-cell directly · updated from PubMed 16 Nov 2026
Study type 0 clinical trials · 1 observational · 4 human data · 5 preclinical · 4 unclassified
Themes 3 themes
-
Immune Cell Interactions
Single-cell, spatial and multi-omics profiling is mapping how B cells interact with T cells, NK cells and tissue-specific immune networks. Genetic variants, including rs57494551, are linked to IgM+ CXCR5+ B-cell infiltration and disease risk. Immune-metabolic pathways and tertiary lymphoid structures are emerging as therapeutic targets, while AB-101 aims to enhance antibody-mediated cytotoxicity. The common direction is mechanistic immune mapping, but therapeutic benefit remains disease-specific.
6 papers · 42.9%
-
Myasthenia Gravis Therapies
Myasthenia gravis treatment is moving toward more targeted approaches alongside comparative evaluation of established therapies. Antigen-specific chimeric autoantibody receptor T cells are being developed to eliminate acetylcholine receptor-specific B cells. Clinical trials and Bayesian network analysis emphasize efficacy, safety, combination therapy and immune reconstitution. Whether these strategies produce durable benefit with acceptable immune effects remains open.
3 papers · 21.4%
-
Others — Antigen Targeting and Safety
Vaccine development is moving toward multi-epitope, mosaic and intranasal designs that seek broader, more durable protection. Epitope screening and antigen avidity recur as ways to shape B-cell maturation and clonal hierarchy. SARS-CoV-2, SARS-CoV, human metapneumovirus and varicella-zoster virus provide the main testing ground. Teclistamab pharmacovigilance adds a separate focus on adverse-event detection rather than a shared vaccine direction.
5 papers · 35.7%
Papers
The 14 papers from the last 6 months that study b-cell directly, newest first, by theme and by study type. Study types come from PubMed publication types and MeSH headings.
By theme
Immune Cell Interactions (6)
- Single-Cell Profiling Reveals Clonally Expanded CX3CR1+ T Cells in Anti-NMDA Receptor Encephalitis. Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 9 Sept 2026 PMID 42711907
- rs57494551 increases CXCR5 expression and IgM+ CXCR5+ B-cell infiltration in the portal area of primary biliary cholangitis. Journal of gastroenterology · 10 Aug 2026 PMID 42573624
- Targeting the immune-metabolic axis reverses orthodontics-induced systemic pathology. Signal transduction and targeted therapy · 2 Aug 2026 PMID 42543382
- High affinity CD16v/v allogeneic NK cell therapy, AB-101, enhances antibody-mediated cytotoxicity in B-cell driven diseases. Cytotherapy · 20 Jul 2026 PMID 42475795
- Spatial multi-omics implicate the interaction between Tpex and B cells in tertiary lymphoid structures after neoadjuvant therapy. Cancer discovery · 24 Jun 2026 PMID 42339989
- Immune cell-specific genetic architecture of Alzheimer's disease revealed by multi-omics analysis for therapeutic target discovery and prioritization. Translational psychiatry · 22 Jun 2026 PMID 42331779
Myasthenia Gravis Therapies (3)
- Generalized myasthenia gravis: Clinical trials to watch. Med (New York, N.Y.) · 11 Sept 2026 PMID 42727567
- Bispecific chimeric autoantibody receptor T cells eliminate acetylcholine receptor-specific B cells in myasthenia gravis models. Nature communications · 20 Aug 2026 PMID 42624846
- Comparison of the Efficacy and Safety of Myasthenia Gravis Treatments: A Bayesian Network Meta-Analysis. Neurology · 17 Jul 2026 PMID 42467874
Others — Antigen Targeting and Safety (5)
- Computational prediction of a multi-epitope Human Metapneumovirus vaccine candidate through integrated reverse vaccinology and pan-genomic approaches. PloS one · 15 Sept 2026 PMID 42743349
- Screening and identification of B-cell epitopes on the gH protein of varicella-zoster virus. Archives of microbiology · 15 Sept 2026 PMID 42742725
- Teclistamab-associated adverse events: a disproportionality analysis of the FDA adverse event reporting system. Hematology (Amsterdam, Netherlands) · 15 Sept 2026 PMID 42742109
- Immunization with mosaic nanoparticles reveals that antigen avidity shapes the clonal hierarchy of the B cell response. Science translational medicine · 12 Aug 2026 PMID 42585293
- Broad and durable protection against SARS-CoV-2 and SARS-CoV by an intranasal chimpanzee adenovirus vaccine expressing tandem RBDs and nucleocapsid. PLoS pathogens · 24 Jul 2026 PMID 42497177
By study type
Observational studies and case reports (1)
- Teclistamab-associated adverse events: a disproportionality analysis of the FDA adverse event reporting system. Hematology (Amsterdam, Netherlands) · 15 Sept 2026 PMID 42742109
Human data, design not indexed (4)
- Computational prediction of a multi-epitope Human Metapneumovirus vaccine candidate through integrated reverse vaccinology and pan-genomic approaches. PloS one · 15 Sept 2026 PMID 42743349
- Screening and identification of B-cell epitopes on the gH protein of varicella-zoster virus. Archives of microbiology · 15 Sept 2026 PMID 42742725
- Generalized myasthenia gravis: Clinical trials to watch. Med (New York, N.Y.) · 11 Sept 2026 PMID 42727567
- Comparison of the Efficacy and Safety of Myasthenia Gravis Treatments: A Bayesian Network Meta-Analysis. Neurology · 17 Jul 2026 PMID 42467874
Preclinical: animal, cell and lab studies (5)
- Bispecific chimeric autoantibody receptor T cells eliminate acetylcholine receptor-specific B cells in myasthenia gravis models. Nature communications · 20 Aug 2026 PMID 42624846
- Immunization with mosaic nanoparticles reveals that antigen avidity shapes the clonal hierarchy of the B cell response. Science translational medicine · 12 Aug 2026 PMID 42585293
- Targeting the immune-metabolic axis reverses orthodontics-induced systemic pathology. Signal transduction and targeted therapy · 2 Aug 2026 PMID 42543382
- Broad and durable protection against SARS-CoV-2 and SARS-CoV by an intranasal chimpanzee adenovirus vaccine expressing tandem RBDs and nucleocapsid. PLoS pathogens · 24 Jul 2026 PMID 42497177
- High affinity CD16v/v allogeneic NK cell therapy, AB-101, enhances antibody-mediated cytotoxicity in B-cell driven diseases. Cytotherapy · 20 Jul 2026 PMID 42475795
Unclassified: not yet indexed with MeSH (4)
- Single-Cell Profiling Reveals Clonally Expanded CX3CR1+ T Cells in Anti-NMDA Receptor Encephalitis. Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 9 Sept 2026 PMID 42711907
- rs57494551 increases CXCR5 expression and IgM+ CXCR5+ B-cell infiltration in the portal area of primary biliary cholangitis. Journal of gastroenterology · 10 Aug 2026 PMID 42573624
- Spatial multi-omics implicate the interaction between Tpex and B cells in tertiary lymphoid structures after neoadjuvant therapy. Cancer discovery · 24 Jun 2026 PMID 42339989
- Immune cell-specific genetic architecture of Alzheimer's disease revealed by multi-omics analysis for therapeutic target discovery and prioritization. Translational psychiatry · 22 Jun 2026 PMID 42331779
Written from 14 PubMed abstracts, each one listed by PMID above. Published: 2026-06-14. Last written: 2026-09-17 by GPT. Drafted by language models from published abstracts; not medical advice.